Skip to main content
Clinical Trials/TCTR20230217004
TCTR20230217004
Completed
Phase 2

Comparison Efficacy of Intraarticular Knee Injection in Knee Osteoarthritis With Leukocyte-rich and Leukocyte-poor Platelet-rich Plasma

Queen Savang Vadhana Memorial Hospital0 sites71 target enrollmentFebruary 17, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Osteoarthritis of the knee
Sponsor
Queen Savang Vadhana Memorial Hospital
Enrollment
71
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 17, 2023
End Date
November 3, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age greater than or equal to 50 years old,
  • Plain radiographs knee AP shows Kellgren\-Lawrence classification 1\-4,
  • Refuse the use of NSAIDs for 2 weeks.

Exclusion Criteria

  • 1\) Previous intra\-articular injection therapy in the past 6 months;
  • 2\) Previously treated with intra\-knee PRP injection;
  • 3\) History of knee arthritis from other causes such as rheumatoid arthritis, pseudogout or infectious joints
  • 4\) History of blood disorder including anemia and thrombocytopenia (Hb \< 12 g/dl, plt \< 150,000/ml )
  • 5\) History of surgery on the aforementioned knee
  • 6\) Obvious knee deformity (valgus \> 15, varus \> 20, flexion ROM \< 90, extension lag \> 20\)
  • 7\) Pregnancy and lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials